Newron Pharmaceuticals S.p.A. (SWX:NWRN)

Newron Pharmaceuticals Revenue

In the year 2025, Newron Pharmaceuticals had annual revenue of 19.13M EUR, down -62.78%. Newron Pharmaceuticals had revenue of 7.23M in the half year ending December 31, 2025, with 102.86% growth.

• Revenue: 19.13M EUR
• Revenue Growth: -62.78%
• P/S Ratio: 19.16
• Revenue / Employee: 708.37K EUR
• Employees: 27
• Market Cap: 341.22M CHF

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	19.13M	-32.26M	-62.78%
Dec 31, 2024	51.39M	42.33M	467.41%
Dec 31, 2023	9.06M	2.96M	48.62%
Dec 31, 2022	6.09M	332.00K	5.76%
Dec 31, 2021	5.76M	504.00K	9.59%